2023
COMPARISON OF IN - HOSPITAL OUTCOMES AND THIRTY - DAY READMISSION RATES BETWEEN PATIENTS WHO UNDERWENT TAVR VERSUS SAVR FOR AORTIC STENOSIS IN LIVER CIRRHOSIS: RESULTS FROM NATIONWIDE READMISSIONS DATABASE
Aggarwal A, Jang S, Webber F, Shkolnik E, Pinto E, Lancaster G, Zarich S. COMPARISON OF IN - HOSPITAL OUTCOMES AND THIRTY - DAY READMISSION RATES BETWEEN PATIENTS WHO UNDERWENT TAVR VERSUS SAVR FOR AORTIC STENOSIS IN LIVER CIRRHOSIS: RESULTS FROM NATIONWIDE READMISSIONS DATABASE. Journal Of The American College Of Cardiology 2023, 81: 1020. DOI: 10.1016/s0735-1097(23)01464-x.Peer-Reviewed Original Research
2021
Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis
Jang S, Yeo I, Jonas C, Goyal P, Cheung J, Feldman D, McCullough S, Krishnan U, Narotsky D, Singh H, Minutello R, Bergman G, Wong S, Kim L. Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis. Journal Of Clinical Medicine 2021, 10: 3701. PMID: 34441995, PMCID: PMC8397058, DOI: 10.3390/jcm10163701.Peer-Reviewed Original ResearchTTS patientsReadmission ratesA Nationwide Readmissions Database AnalysisNationwide Readmissions Database AnalysisThirty-day readmission ratesNon-cardiac causesNationwide Readmissions DatabasePresence of malignancyIndex hospitalizationTakotsubo syndromeOverall burdenCommon causePatientsReadmissionMalignancyDatabase analysisHospitalizationCauseComorbiditiesSyndrome